4595 — Mizuho Medy Co Income Statement
0.000.00%
Last trade - 00:00
- ¥31bn
- ¥21bn
- ¥11bn
- 86
- 73
- 78
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,428 | 4,205 | 13,137 | 17,582 | 10,990 |
Cost of Revenue | |||||
Gross Profit | 4,340 | 2,761 | 9,903 | 14,100 | 8,074 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,257 | 3,789 | 6,315 | 6,478 | 5,838 |
Operating Profit | 1,171 | 416 | 6,823 | 11,104 | 5,152 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,171 | 415 | 6,825 | 11,071 | 5,292 |
Provision for Income Taxes | |||||
Net Income After Taxes | 874 | 306 | 4,817 | 7,838 | 3,774 |
Net Income Before Extraordinary Items | |||||
Net Income | 874 | 306 | 4,817 | 7,838 | 3,774 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 874 | 306 | 4,817 | 7,838 | 3,774 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 87.1 | 32.2 | 497 | 823 | 396 |
Dividends per Share | |||||
Special Dividends per Share |